Drug approval
The US Food and Drug Administration (FDA) has approved lenacapavir, a groundbreaking, injectable HIV prevention drug that offers long-lasting protection against HIV infection. Administered once every six months, this game-changing treatment expands prevention options for individuals at risk of HIV infection, particularly those who struggle with daily pill regimens. Unlike
Drug approval
The US Food and Drug Administration has approved lenacapavir, an injectable drug that offers long-lasting protection against HIV infection. This new treatment marks a significant advancement in expanding prevention options for people at risk of HIV infection, offering a convenient and highly effective alternative to daily pills. Key Takeaways: * Lenacapavir
Drug approval
The United States Food and Drug Administration has approved Lenacapavir (LEN), a highly effective HIV prevention medicine that can reduce the risk of transmission by 99.9 per cent. This approval has significant implications for global efforts to combat the spread of HIV, particularly in India, where Dr. I.S.
Drug approval
Researchers at Rockefeller's Laboratory of Bacteriology and MSKCC's Structural Biology Laboratory have made a groundbreaking discovery in the field of bacterial immunity. By studying CRISPR systems, specifically CARF effectors, they have identified a new protein called Cat1, which plays a crucial role in defending bacteria against
COVID-19
The US Food and Drug Administration (FDA) has announced a drastic change in its COVID-19 vaccine policy, only approving updated vaccines for adults over 65 and other Americans who may be at greater risk if they get infected. This move, driven by the antivaxxer ideologies of FDA Commissioner Marty Makary
COVID-19
Moderna Inc's (NASDAQ:MRNA, ETR:0QF) shares surged by more than 6.5% on Tuesday, driven by the US Food and Drug Administration's (FDA) updated guidelines for COVID-19 vaccine approvals. The new framework maintains the status quo for the company's core market, particularly for
COVID-19
The US FDA has approved Novavax's protein-based COVID-19 vaccine, Nuvaxovid, for adults aged 65 and older, as well as individuals between 12 and 64 with underlying health conditions. The vaccine has been available under emergency use authorization since July 2022. Novavax had initially sought approval for a broader
COVID-19
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug Administration (FDA) wants more data before it can be approved. The study, published in the Journal of the American Medical Association, focused on adults ages 50 and older
Drug approval
The U.S. Food and Drug Administration has approved AbbVie's Vyalev, an infusion-based treatment for Parkinson's disease that provides a continuous source of levodopa/carbidopa, increasing "on" time and reducing motor fluctuations. This innovative delivery method, similar to insulin therapy for diabetes, has been
Drug approval
The Shangsheng influenza vaccine series has achieved a significant milestone by becoming the first unified dosage form for people aged 6 months and above in China. This achievement follows the approval by the National Medical Products Administration of the supplementary application for the trivalent influenza virus split vaccine (0.5ml/
United States. Food and Drug Administration
Dozens of pharmaceutical executives, including top leaders from Pfizer, Novartis, Biogen, and Merck, have signed a letter criticizing a recent US judicial ruling that could block access to the widely used abortion pill mifepristone. The ruling, issued by Texas federal judge Matthew Kacsmaryk, has been condemned as an attack on
United States. Food and Drug Administration
Democratic Rep. Alexandria Ocasio-Cortez and other lawmakers have called on the Biden administration to ignore a federal judge's ruling in Texas suspending the approval of mifepristone, a common abortion pill. The ruling, issued by a Trump-appointed judge, has been met with criticism from Democrats, who argue that the
